Skip to content
Teva Pharma Industries Ltd ADR

Appaloosa Management Teva Pharma Industries Ltd ADR transactions over time

TEVA-OLD

Teva Pharma Industries Ltd ADR historical holders

total: 10

Transactions details

Total transactions:
3
New positions:
1
Sold out:
1
Reduced:
1
Held since:
2016 Q4
Held for:
2 quarters
Latest activity:
2017 Q2
David Tepper has been an institutional investor in Teva Pharma Industries Ltd ADR (TEVA-OLD) since 2016 Q4. According to 2026 Q2 report, David Tepper doesn't hold any shares. The fund/company first acquired TEVA-OLD in 2016 Q4, initially purchasing about 5.05M shares. Since the initial investment, Appaloosa Management has made 2 more transactions in this position.

When did David Tepper exit their TEVA-OLD position?

David Tepper no longer holds Teva Pharma Industries Ltd ADR (TEVA-OLD). They sold off their entire position in 2017 Q2, closing out an investment that began in 2016 Q4.

When did David Tepper first invest in TEVA-OLD?

David Tepper first invested in Teva Pharma Industries Ltd ADR (TEVA-OLD) in 2016 Q4 at the reported quarter-end price of $36.25 per share, acquiring 5,053,000 shares in their initial purchase.

What is David Tepper's average cost basis for TEVA-OLD?

Based on historical transaction data, David Tepper's estimated cost basis for Teva Pharma Industries Ltd ADR (TEVA-OLD) is approximately $36.25 per share. This represents their average reported price* across all buy transactions.

Estimated cost basis*

Weighted AVG buy price:
$36.25
Weighted AVG sell price:
$32.09

TEVA-OLD transactions history by Appaloosa Management

3 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2017 Q2
0.00%
$32.09
-100% (-2,175,000)
2017 Q1
1.22%
$32.09
-56.96% (-2,878,000)
2016 Q4
3.38%
$36.25
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.